Form 4 for AIM AIM ImmunoTech Inc.
Accepted 2024-03-18 00:00:00 ET · period of report 2024-03-15 · accession 0001493152-24-010267 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-03-18 | 2024-03-15 | AIM | Equels Thomas K | CEO, Pres, Dir | P - Purchase | $0.33 | +75.8K | 716.5K | +12% | +$25.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-03-15 | P | A | 75,758 | $0.33 | 716,455 | D | — | — |